RICHARD F POPS Insider Trading $XLRN ACCELERON PHARMA INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for RICHARD F POPS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RICHARD F POPS. RICHARD F POPS is Chief Executive Officer in ALKERMES INC ($ALKS) and Director in ALKERMES INC ($ALKS) and President and CEO in ALKERMES INC ($ALKS) and Director in NEUROCRINE BIOSCIENCES INC ($NBIX) and Director in ACCELERON PHARMA INC ($XLRN) and Director and CEO, Alkermes plc in Alkermes plc. ($ALKS) and Director in Epizyme, Inc. ($EPZM).
RICHARD F POPS in ACCELERON PHARMA INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of RICHARD F POPS: Director
Holdings: 32,500 shares
Current Value: $771,550
Latest Transaction: Jan 29 2019
$XLRN Market Capitalization: $879.48M
$XLRN Previous Close: $23.74
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of RICHARD F POPS in ACCELERON PHARMA INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, XLRN, ALKS, ALKS, EPZM, NBIX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 29 2019 | XLRN | ACCELERON PHARMA I ... | POPS RICHARD F | Director | Option Exercise | A | 41.64 | 7,500 | 312,300 | 7,500 | |
| Jan 29 2019 | XLRN | ACCELERON PHARMA I ... | POPS RICHARD F | Director | Grant | A | 0.00 | 1,250 | 0 | 32,500 | 31.3 K to 32.5 K (+4.00 %) |
| Mar 08 2018 | XLRN | ACCELERON PHARMA I ... | POPS RICHARD F | Director | Option Exercise | M | 5.08 | 37,500 | 190,500 | 0 | |
| Mar 08 2018 | XLRN | ACCELERON PHARMA I ... | POPS RICHARD F | Director | Sell | S | 42.32 | 2,902 | 122,813 | 31,250 | 34.2 K to 31.3 K (-8.50 %) |
| Mar 08 2018 | XLRN | ACCELERON PHARMA I ... | POPS RICHARD F | Director | Sell | S | 41.34 | 34,598 | 1,430,281 | 34,152 | 68.8 K to 34.2 K (-50.32 %) |
| Mar 08 2018 | XLRN | ACCELERON PHARMA I ... | POPS RICHARD F | Director | Buy | M | 5.08 | 37,500 | 190,500 | 68,750 | 31.3 K to 68.8 K (+120.00 %) |
| Mar 05 2018 | XLRN | ACCELERON PHARMA I ... | POPS RICHARD F | Director | Option Exercise | A | 40.61 | 7,500 | 304,575 | 7,500 | |
| Mar 05 2018 | XLRN | ACCELERON PHARMA I ... | POPS RICHARD F | Director | Grant | A | 0.00 | 1,250 | 0 | 31,250 | 30 K to 31.3 K (+4.17 %) |
| Mar 14 2017 | XLRN | ACCELERON PHARMA I ... | POPS RICHARD F | Director | Option Exercise | A | 30.17 | 7,500 | 226,275 | 7,500 | |
| Mar 14 2017 | XLRN | ACCELERON PHARMA I ... | POPS RICHARD F | Director | Grant | A | 0.00 | 1,250 | 0 | 30,000 | 28.8 K to 30 K (+4.35 %) |
| Mar 07 2016 | XLRN | ACCELERON PHARMA I ... | POPS RICHARD F | Director | Option Exercise | A | 27.97 | 10,000 | 279,700 | 10,000 |
Page: 1